The increasing use of co-processed excipients to improve the dissolution, bioavailability, and solubility of recently developed active pharmaceutical ingredients (APIs), rapid growth in the generics market due to the patent expiration of many blockbuster drugs and increasing development of orally disintegrating tablets (ODT) are expected to propel the growth of this market.
The global Sugar-Based Excipients Market is segmented on the basis of product, type, functionality, formulation, and region.
The global Sugar-Based Excipients Market is segmented on the basis of product, type, functionality, formulation, and region.
Don’t miss out on business opportunities in
Geographically, the global Sugar-Based Excipients Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, Europe commanded a major share of the global market. Europe’s largest share is primarily attributed to the increasing investments in drug development, increasing the production of generic drugs, and favorable government initiatives in the region. North America, represents the second largest market for sugar excipients.
Factors such as the presence of a large number of global pharmaceutical companies and increasing demand of generic drugs due to patent expiration of blockbuster drugs are majorly contributing to the growth of the market in this region. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the significant growth in the regional healthcare market as well as the pharmaceutical industry, growing scientific base and capability, and favorable government policies, and low-cost manufacturing advantages in this region.
Download PDF (Sugar Excipients Market):
No comments:
Post a Comment